Phase 2 EVOKE-02 Study of Sacituzumab Govitecan and Pembrolizumab +/- Platinum in First-Line Metastatic NSCLC Reck, M., Liu, S. V., Owen, S. P., Garon, E. B., Neal, J. W., Vicente, D., Mekan, S. F., Safavi, F., Fernando, N., Mok, T. K. ELSEVIER SCIENCE INC. 2022: S448

View details for Web of Science ID 000858678101227